162 related articles for article (PubMed ID: 35996487)
1. Evaluation of Efficacy and Safety of Low-Fluence Q-Switched 1064-nm Laser in Infra-orbital Hyperpigmentation Based on Biometric Parameters.
Alavi S; Goodarzi A; Nilforoushzadeh MA; Mansouri P; Jafari MA; Hejazi S; Azizian Z
J Lasers Med Sci; 2022; 13():e16. PubMed ID: 35996487
[No Abstract] [Full Text] [Related]
2. Comparison of carboxy therapy and fractional Q-switched ND:YAG laser on periorbital dark circles treatment: a clinical trial.
Nilforoushzadeh MA; Heidari-Kharaji M; Alavi S; Zolghadr S; Mahmoudbeyk M; Nikkhah N
Lasers Med Sci; 2021 Dec; 36(9):1927-1934. PubMed ID: 33638096
[TBL] [Abstract][Full Text] [Related]
3. The investigation and comparison of the efficacy and safety of stromal vascular fraction (SVF), platelet rich plasma (PRP), and 1064-nm Q-switched Nd:YAG laser in reducing nanofat treated infraorbital dark circles and wrinkles: A controlled blinded randomized clinical trial.
Roohaninasab M; Ahmadi M; Dehghani A; Zare S; Goodarzi A; Nouri M; Ebrahimi Z; Behrangi E; Nilforoushzadeh MA
Skin Res Technol; 2024 Jun; 30(6):e13793. PubMed ID: 38899793
[TBL] [Abstract][Full Text] [Related]
4. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
5. Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trial.
Limpjaroenviriyakul N; Jurairattanaporn N; Kamanamool N; Rojhirunsakool S; Kanokrungsee S; Udompataikul M
Lasers Med Sci; 2020 Feb; 35(1):165-171. PubMed ID: 31177406
[TBL] [Abstract][Full Text] [Related]
6. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
7. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
8. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
9. Combining Low Power Fractional CO
Esmat S; Z Elramly A; Shahin D; Hilal RF
Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
[TBL] [Abstract][Full Text] [Related]
10. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota.
Chan HH; Ying SY; Ho WS; Kono T; King WW
Dermatol Surg; 2000 Oct; 26(10):919-22. PubMed ID: 11050493
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy alone and in combination with erbium:YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis.
Nilforoushzadeh MA; Zolghadr S; Heidari-Kharaji M; Alavi S; Mahmoudbeyk M
Lasers Med Sci; 2020 Jul; 35(5):1171-1177. PubMed ID: 31916020
[TBL] [Abstract][Full Text] [Related]
12. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
13. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
[TBL] [Abstract][Full Text] [Related]
15. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of Q-switched Nd:YAG laser treatment of hyperpigmented split-thickness skin grafts.
Tonaree W; Eimpunth S; Kamnerdnakta S; Kongkunnavat N; Chuangsuwanich A
Lasers Med Sci; 2022 Jul; 37(5):2381-2386. PubMed ID: 35094175
[TBL] [Abstract][Full Text] [Related]
17. Assessing the effectiveness of the combination therapy with fractional Er-YAG laser and platelet-rich plasma in treatment of periorbital dark circles patients: A clinical trial.
Nilforoushzadeh MA; Heidari-Kharaji M; Alavi S; Mahmoudbeyk M; Torkamaniha E; Peyrovan A; Nouri M; Zare S
J Cosmet Dermatol; 2021 Nov; 20(11):3526-3536. PubMed ID: 33638928
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
19. Non-Ablative 1927 nm Fractional Thulium Fiber Laser: New, Promising Treatment Modality for Riehl's Melanosis.
Kim SM; Hwang S; Almurayshid A; Park MY; Oh SH
Lasers Surg Med; 2021 Jul; 53(5):640-646. PubMed ID: 33259661
[TBL] [Abstract][Full Text] [Related]
20. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma.
Hong JK; Shin SH; Park SJ; Seo SJ; Park KY
J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
